US public’s likelihood of getting COVID-19 vaccine
Editor's Note
This study, led by researchers from the University of California, Los Angeles, analyzed biweekly nationally representative survey data to describe changes over time in the public’s likelihood of getting a COVID-19 vaccine.
Among 8,167 respondents, the likelihood of getting a COVID-19 vaccine declined from 74% in early April to 56% in early December, despite the early November reports of high vaccine efficacy for two vaccines in phase 3 trials, prior to Emergency Use Authorization.
The significant declines were observed in both men and women and in all age, racial/ethnic, and educational subgroups.
The authors concluded that educational campaigns to raise the public’s willingness to consider receiving the COVID-19 vaccine are needed.
Free Daily News
- Artificial disc replacement proves safe, efficient, cost-saving in outpatient spine surgery
- Hospital-affiliated doctors drive highest costs by avoiding lower-cost sites
- Imposter syndrome widespread among surgical trainees, disproportionately affects women
- Global nursing workforce grows but inequities jeopardize health progress
- Largest US healthcare fraud case reveals billions in false Medicare, Medicaid claims and vast schemes nationwide
- Hospital margins improve as outpatient revenue accelerates, but costs loom
- Breast cancer surgery delays tied to higher upstaging, faster tumor growth
- Exercise programs ease stress and burnout for nurses, review finds
- WHO and robotic surgery society partner to expand global access to telesurgery
- Health systems lean toward established partners for AI adoption